Malabar Foundation Of Neuro And Cardiac Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 10.00 K
as on 19-12-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 12.17%
(FY 2022)
- Ebitda 17.46%
(FY 2022)
- Net Worth -118.13%
(FY 2022)
- Total Assets %
(FY 2022)
About Malabar Foundation Of Neuro And Cardiac Care
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Reeda Kunhimangalam and Ovallaththazha Sujith serve as directors at the Company.
- CIN/LLPIN
U85300KL2020NPL063695
- Company No.
063695
- Company Classification
Private Not For Profit Company
- Incorporation Date
19 Aug 2020
- Date of AGM
20 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Malabar Foundation Of Neuro And Cardiac Care?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Reeda Kunhimangalam  | Director | 19-Aug-2020 | Current |
| Ovallaththazha Sujith | Director | 19-Aug-2020 | Current |
Financial Performance of Malabar Foundation Of Neuro And Cardiac Care.
Malabar Foundation Of Neuro And Cardiac Care, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 118.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Malabar Foundation Of Neuro And Cardiac Care?
Unlock access to Malabar Foundation Of Neuro And Cardiac Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Reussie Pharma Private LimitedActive 8 years 9 monthsReeda Kunhimangalam and Ovallaththazha Sujith are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Malabar Foundation Of Neuro And Cardiac Care?
Malabar Foundation Of Neuro And Cardiac Care has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Malabar Foundation Of Neuro And Cardiac Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Malabar Foundation Of Neuro And Cardiac Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
